FDA approves test of Cuban-developed lung cancer treatment
WASHINGTON — The U.S. Food and Drug Administration has given approval for U.S. clinical trials of a Cuban-developed lung cancer vaccine that stimulates cancer patients own immune systems.
WASHINGTON — The U.S. Food and Drug Administration has given approval for U.S. clinical trials of a Cuban-developed lung cancer vaccine that stimulates cancer patients own immune systems.
Please help local businesses by taking an online survey to help us navigate through these unprecedented times. None of the responses will be shared or used for any other purpose except to better serve our community. The survey is at: www.pulsepoll.com $1,000 is being awarded. Everyone completing the survey will be able to enter a contest to Win as our way of saying, "Thank You" for your time. Thank You!